bio:cap europe 2026

bio:cap europe 2026 will take place from June 9 to 11, 2026, at CityCube Berlin (Messe Berlin), combining a conference, exhibition, and curated networking formats into a unique investival. Its mission is to connect breakthrough science with the funding needed to turn ideas into real-world impact, focusing on sectors such as biotechnology, pharma, diagnostics, techbio, data, and artificial intelligence.

Over three days, the event brings together startups, scale-ups, investors, industry leaders, researchers, and policymakers. The program features keynotes, panel discussions, and deep-dive sessions covering topics like AI-driven healthcare, data-enabled life sciences, regulatory frameworks, and innovation scaling strategies. A key component is curated matchmaking, enabling targeted one-on-one meetings between founders and investors.

Confirmed speakers include Prof. Dr. Stefan W. Hell (Max Planck Institute for Medical Research), Stefan Oelrich (Bayer AG), Nicole Büttner (Merantix), and representatives from government and international organizations. In addition to the conference content, participants can engage in networking formats and evening events, creating opportunities for collaboration across Europe’s innovation ecosystem.

Key Parameters:
Date: June 9–11, 2026
Location: CityCube Berlin, Messe Berlin
Organizer: Messe Berlin
Partners: Charité, Berlin Institute of Health at Charité, Hasso Plattner Institute
Format: Investival (conference, expo, matchmaking, networking)
Program: Keynotes, panels, deep dives, pitch sessions, matchmaking
Topics: Life sciences, AI, techbio, pharma, diagnostics, data economy
Target Audience: Startups, investors, pharma & biotech, research, policymakers
Participation: Ticket required